M&A Deal Summary

Horizon Discovery Group Acquires Haplogen Genomics

On January 8, 2015, Horizon Discovery Group acquired life science company Haplogen Genomics for 8M EUR

Acquisition Highlights
  • This is Horizon Discovery Group’s 2nd transaction in the Life Science sector.
  • This is Horizon Discovery Group’s largest (disclosed) transaction.
  • This is Horizon Discovery Group’s 1st transaction in Austria.

M&A Deal Summary

Date 2015-01-08
Target Haplogen Genomics
Sector Life Science
Buyer(s) Horizon Discovery Group
Deal Type Add-on Acquisition
Deal Value 8M EUR

Target

Haplogen Genomics

Vienna, Austria
Haplogen Genomics GmbH is a biotechnology company generate precisely engineered human cell lines efficiently and at a price that places genome editing within the reach of the broader academic research market through the use of haploid cells.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Horizon Discovery Group

Cambridge, United Kingdom

Category Company
Founded 2007
Sector Healthcare Services
Employees398
Revenue 58M GBP (2019)
DESCRIPTION

Horizon Discovery Group PLC is an international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines. Horizon Discovery Group was founded in 2007 and is based in Cambridge, the United Kingdom.


DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
Country: Austria M&A 1 of 1
Year: 2015 M&A 1 of 1
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-09-29 SAGE Labs

St. Louis, Missouri, United States

SAGE Labs, Inc. is a provider of next-generation research models, including knockout rat models, and extensive support services.

Buy $48M